Does Endotoxin Tolerance Prevent the Release of Inflammatory Monokines (Interleukin 1, Interleukin 6, or Tumor Necrosis Factor) During Sepsis?
- 1 February 1992
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Surgery
- Vol. 127 (2) , 191-197
- https://doi.org/10.1001/archsurg.1992.01420020077011
Abstract
• Mice were subjected to sepsis by cecal ligation and puncture to determine whether macrophages from endotoxin-tolerant C3H/HeJ mice are also activated systemically to release inflammatory monokines associated with septic mortality. Blood levels of both tumor necrosis factor and interleukin 6 were significantly elevated during the first 1 to 4 hours of sepsis as compared with sham controls. Peritoneal macrophages from septic mice exhibited a marked spontaneous release of interleukin 1, interleukin 6, and tumor necrosis factor at 1 hour. However, the addition of endotoxin to macrophage cultures taken from septic mice had no further stimulatory effect. Sham controls alternatively showed no significant innate monokine release, but their macrophages did release increased monokine numbers in response to endotoxin. These results indicate that the spontaneous macrophage release of these monokines is comparable with that previously observed in endotoxin-sensitive mice, suggesting a common mechanism by which macrophages are primed by traumatic injury by an agent other than endotoxin to release monokines during sepsis. Thus, the administration of agents that decrease or prevent the deleterious effects of systemic inflammatory mediators during sepsis could be useful adjuvants in those clinical situations where the bacterial origin is unknown. (Arch Surg. 1992;127:191-197)Keywords
This publication has 14 references indexed in Scilit:
- Hemorrhage induces an increase in serum TNF which is not associated with elevated levels of endotoxinCytokine, 1990
- Wehi 164 Subclone 13 Assay for Tnf: Sensitivity, Specificity, and ReliabilityImmunological Investigations, 1989
- Endotoxin, tumor necrosis factor-α and interleukin 1 induce interleukin 6 production in vivoClinical Immunology and Immunopathology, 1989
- Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humansCritical Care Medicine, 1989
- Biological activity of recombinant murine interleukin-6 in interleukin-1 T cell assaysJournal of Immunological Methods, 1989
- The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.The Journal of Experimental Medicine, 1989
- Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits.Journal of Clinical Investigation, 1988
- Multiple actions of interleukin 6 within a cytokine networkImmunology Today, 1988
- Hemorrhage Without Tissue Trauma Produces Immunosuppression and Enhances Susceptibility to SepsisArchives of Surgery, 1987
- Sepsis and septic shock—A review of laboratory models and a proposalJournal of Surgical Research, 1980